Literature DB >> 10848738

Mucosal human papillomavirus types in squamous cell carcinomas of the uterine cervix and subsequently on fingers.

O Forslund1, P Nordin, B G Hansson.   

Abstract

Human papillomavirus (HPV), especially type 16, is causally involved in the pathogenesis of anogenital cancer. There is an increasing number of reports of HPV infections in squamous cell carcinoma (SCC) of the fingers. A search of the Swedish cancer register covering the period 1958-94 inclusive for women with a history of genital and upper extremity SCC revealed 63 cases. Archival material from both cervical and cutaneous lesions was traced and analysed for the presence of HPV DNA in 32 of these patients. A newly developed 'neighbour primer' polymerase chain reaction (PCR) for HPV 16 DNA, aimed at overcoming the obstacle of cross-linked target DNA, was shown to be superior to conventional general and type-specific HPV PCR tests. HPV DNA was significantly more frequently found in digital tumours than in tumours at other cutaneous sites of the upper extremities [67% (10 of 15) vs. 7% (three of 43); P < 0.001]. Among 13 patients with a history of both cervical and finger SCC, HPV 16 was found in cervical samples from seven patients. From five of these seven patients, HPV 16 was also present in the corresponding finger lesions. The results support the hypothesis of a possible transmission of patients' genital HPV infections to fingers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848738     DOI: 10.1046/j.1365-2133.2000.03540.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  Bowenoid Papulosis of the Vulva and Subsequent Periungual Bowen's Disease Induced by the Same Mucosal HPVs.

Authors:  Woo-Haing Shim; Hyun-Je Park; Hoon-Soo Kim; Su-Han Kim; Do-Sang Jung; Hyun-Chang Ko; Byung-Soo Kim; Moon-Bum Kim; Kyung-Sool Kwon
Journal:  Ann Dermatol       Date:  2011-11-03       Impact factor: 1.444

2.  Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study.

Authors:  Talía Malagón; Karolina Louvanto; Michel Wissing; Ann N Burchell; Pierre-Paul Tellier; Mariam El-Zein; François Coutlée; Eduardo L Franco
Journal:  Lancet Infect Dis       Date:  2019-02-10       Impact factor: 25.071

3.  Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species.

Authors:  Alessandra Handisurya; Patricia M Day; Cynthia D Thompson; Christopher B Buck; Kihyuck Kwak; Richard B S Roden; Douglas R Lowy; John T Schiller
Journal:  Virology       Date:  2012-09-15       Impact factor: 3.616

Review 4.  Dermatologic manifestations of HPV in HIV-infected individuals.

Authors:  Rachel H Gormley; Carrie L Kovarik
Journal:  Curr HIV/AIDS Rep       Date:  2009-08       Impact factor: 5.071

5.  Finger Pad Squamous Cell Carcinoma: Report of Squamous Cell Carcinoma of the Distal Palmar Digit and Review of Associated Risk Factors, Mimickers, and Treatment of Squamous Cell Carcinoma of Ventral Hand Digits.

Authors:  Philip R Cohen; S Brian Jiang
Journal:  J Clin Aesthet Dermatol       Date:  2017-08-01

6.  The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma.

Authors:  Jimmy T Efird; Amanda E Toland; C Suzanne Lea; Christopher J Phillips
Journal:  Clin Med Insights Oncol       Date:  2011-03-27

7.  Vulval intraepithelial neoplasia and periungual Bowen's disease concordant for mucosal (HPV-34) and epidermodysplasia verruciformis (HPV-21) human papillomavirus types.

Authors:  A L Ekeowa-Anderson; C A Harwood; C M Perrett; A Sahota; H Annan; H Ran; I M Leigh; K L Gibbon
Journal:  Clin Exp Dermatol       Date:  2007-03-14       Impact factor: 3.470

Review 8.  Hygienic hand antiseptics: should they not have activity and label claims against viruses?

Authors:  Syed A Sattar; V Susan Springthorpe; Jason Tetro; Robert Vashon; Bruce Keswick
Journal:  Am J Infect Control       Date:  2002-10       Impact factor: 2.918

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.